Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling-Reference-Cited by-同舟云学术

Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling

Published:2019-07-29 Issue:8 Volume:10 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Seyfried Felix,Demir Salih,Hörl Rebecca Louise,Stirnweiß Felix Uli,Ryan Jeremy^ORCID,Scheffold Annika,Villalobos-Ortiz Mariana,Boldrin Elena,Zinngrebe Julia,Enzenmüller Stefanie,Jenni Silvia,Tsai Yi-Chien,Bornhauser Beat,Fürstberger Axel,Kraus Johann Michael,Kestler Hans Armin,Bourquin Jean-Pierre,Stilgenbauer Stephan,Letai Anthony,Debatin Klaus-Michael,Meyer Lüder Hinrich

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-019-1801-0.pdf

Reference53 articles.

1. Conter, V. et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 115, 3206–3214 (2010).

2. Pui, C. H. et al. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Lancet Oncol. 16, 465–474 (2015).

3. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

4. Miyashita, T. & Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81, 151–157 (1993).

5. Holleman, A. et al. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 107, 769–776 (2006).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic-modifying agents: the potential game changers in the treatment of hematologic malignancies;Critical Reviews in Oncology/Hematology;2024-09

2. Profiling protein–protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemia;Nature Biomedical Engineering;2024-07-18

3. Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation;Cell Death & Disease;2024-07-03

4. Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening;Heliyon;2024-07

5. Dysregulation of BCL-2 family proteins in blood neoplasm: therapeutic relevance of antineoplastic agent venetoclax;Exploration of Medicine;2024-05-10